VEGFA and cerebral cavernous malformation: Furthermore, HUVEC cells plated with CCM from A549 cells, neutralizing VEGF by using blocking mAb significantly reduced IL-17-induced tube formation, while using IL-17 mAb treated were not affected (Fig. 4c).